LIG1
Basic information
Region (hg38): 19:48115445-48170603
Links
Phenotypes
GenCC
Source:
- immunodeficiency 96 (Strong), mode of inheritance: AR
Clinical Genomic Database
Source:
Condition | Inheritance | Intervention Categories | Intervention/Rationale | Manifestation Categories | References |
---|---|---|---|---|---|
Immunodeficiency 96 | AR | Allergy/Immunology/Infectious; Hematologic | Antiinfectious prophylaxis and early and aggressive treatment of infections and hematologic anomalies may be beneficial; Individuals have been described as affected by hematolgic disturbances, such as anemia requiring RBC transfusions, and awareness may allow early diagnosis and medical management; HSCT has been described | Allergy/Immunology/Infectious; Hematologic | 1351188; 1581963; 30395541 |
ClinVar
This is a list of variants' phenotypes submitted to
- not provided (1 variants)
- Immunodeficiency 96 (1 variants)
Variants pathogenicity by type
Statistics on ClinVar variants can assist in determining whether a specific variant type in the LIG1 gene is commonly pathogenic or not.
In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.
Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.
Variant type | Pathogenic | Likely pathogenic | VUS | Likely benign | Benign | Sum |
---|---|---|---|---|---|---|
synonymous | 174 | 13 | 191 | |||
missense | 221 | 239 | ||||
nonsense | 5 | |||||
start loss | 0 | |||||
frameshift | 7 | |||||
inframe indel | 3 | |||||
splice donor/acceptor (+/-2bp) | 3 | |||||
splice region | 15 | 39 | 3 | 57 | ||
non coding | 122 | 35 | 161 | |||
Total | 1 | 1 | 245 | 305 | 57 |
Highest pathogenic variant AF is 0.0000131
Variants in LIG1
This is a list of pathogenic ClinVar variants found in the LIG1 region.
You can filter this list by clicking the number of variants in the Variants pathogenicity by type table.
Position | Type | Phenotype | Significance | ClinVar |
---|---|---|---|---|
19-48115666-G-A | not specified | Uncertain significance (Dec 26, 2023) | ||
19-48115679-G-C | Uncertain significance (Dec 07, 2021) | |||
19-48115684-C-T | Uncertain significance (Mar 29, 2023) | |||
19-48115685-G-A | Uncertain significance (Mar 20, 2023) | |||
19-48115688-T-G | Uncertain significance (Apr 25, 2022) | |||
19-48115691-T-C | Likely benign (Oct 22, 2023) | |||
19-48115709-T-C | Benign (Jan 25, 2024) | |||
19-48115716-C-T | Uncertain significance (Jul 25, 2022) | |||
19-48115717-G-A | Uncertain significance (Jun 08, 2022) | |||
19-48115728-G-C | not specified | Uncertain significance (Mar 11, 2022) | ||
19-48115734-TGC-T | Likely benign (Sep 08, 2023) | |||
19-48115736-C-G | Likely benign (Jun 23, 2023) | |||
19-48115736-C-T | Likely benign (Jul 17, 2023) | |||
19-48115747-T-C | Likely benign (Feb 21, 2022) | |||
19-48115752-C-T | Likely benign (Jul 31, 2023) | |||
19-48115862-C-G | Likely benign (Dec 20, 2022) | |||
19-48115878-C-T | Uncertain significance (Jun 22, 2022) | |||
19-48115884-T-C | not specified | Uncertain significance (Feb 22, 2023) | ||
19-48115896-C-T | Uncertain significance (May 31, 2021) | |||
19-48115897-C-T | Benign (Aug 01, 2024) | |||
19-48115898-G-A | not specified | Uncertain significance (Aug 10, 2021) | ||
19-48115899-G-A | not specified | Uncertain significance (May 28, 2024) | ||
19-48115904-T-C | Uncertain significance (Feb 22, 2021) | |||
19-48115906-G-A | Likely benign (Mar 26, 2023) | |||
19-48115919-C-T | not specified | Uncertain significance (Jun 07, 2024) |
GnomAD
Source:
Gene | Type | Bio Type | Transcript | Coding Exons | Length |
---|---|---|---|---|---|
LIG1 | protein_coding | protein_coding | ENST00000263274 | 27 | 55159 |
pLI Probability LOF Intolerant | pRec Probability LOF Recessive | Individuals with no LOFs | Individuals with Homozygous LOFs | Individuals with Heterozygous LOFs | Defined | p |
---|---|---|---|---|---|---|
0.00421 | 0.996 | 125709 | 0 | 39 | 125748 | 0.000155 |
Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible in Transcript | |
---|---|---|---|---|---|---|
Missense | 0.820 | 512 | 567 | 0.903 | 0.0000388 | 5914 |
Missense in Polyphen | 167 | 205.95 | 0.81088 | 2016 | ||
Synonymous | -0.696 | 253 | 239 | 1.06 | 0.0000175 | 1847 |
Loss of Function | 4.61 | 14 | 48.7 | 0.288 | 0.00000222 | 594 |
LoF frequencies by population
Ethnicity | Sum of pLOFs | p |
---|---|---|
African & African-American | 0.000271 | 0.000271 |
Ashkenazi Jewish | 0.00 | 0.00 |
East Asian | 0.0000544 | 0.0000544 |
Finnish | 0.000240 | 0.000231 |
European (Non-Finnish) | 0.000213 | 0.000211 |
Middle Eastern | 0.0000544 | 0.0000544 |
South Asian | 0.0000654 | 0.0000653 |
Other | 0.000163 | 0.000163 |
dbNSFP
Source:
- Function
- FUNCTION: DNA ligase that seals nicks in double-stranded DNA during DNA replication, DNA recombination and DNA repair.;
- Pathway
- Nucleotide excision repair - Homo sapiens (human);Base excision repair - Homo sapiens (human);Mismatch repair - Homo sapiens (human);DNA replication - Homo sapiens (human);Nucleotide Excision Repair ;Mismatch repair;Mismatch repair (MMR) directed by MSH2:MSH3 (MutSbeta);Mismatch Repair;DNA Repair;Disease;HIV Life Cycle;HIV Infection;Infectious disease;DNA Replication;Processive synthesis on the lagging strand;Lagging Strand Synthesis;DNA strand elongation;Synthesis of DNA;POLB-Dependent Long Patch Base Excision Repair;S Phase;PCNA-Dependent Long Patch Base Excision Repair;Resolution of AP sites via the multiple-nucleotide patch replacement pathway;Resolution of Abasic Sites (AP sites);Base Excision Repair;Processive synthesis on the C-strand of the telomere;Telomere C-strand (Lagging Strand) Synthesis;Extension of Telomeres;Telomere Maintenance;Chromosome Maintenance;Cell Cycle;Gap-filling DNA repair synthesis and ligation in GG-NER;Global Genome Nucleotide Excision Repair (GG-NER);Cell Cycle, Mitotic;Early Phase of HIV Life Cycle;Gap-filling DNA repair synthesis and ligation in TC-NER;Transcription-Coupled Nucleotide Excision Repair (TC-NER);Nucleotide Excision Repair;Mismatch repair (MMR) directed by MSH2:MSH6 (MutSalpha)
(Consensus)
Recessive Scores
- pRec
- 0.388
Intolerance Scores
- loftool
- 0.547
- rvis_EVS
- 0.37
- rvis_percentile_EVS
- 74.73
Haploinsufficiency Scores
- pHI
- 0.980
- hipred
- Y
- hipred_score
- 0.715
- ghis
- 0.554
Essentials
- essential_gene_CRISPR
- E
- essential_gene_CRISPR2
- S
- essential_gene_gene_trap
- E
- gene_indispensability_pred
- E
- gene_indispensability_score
- 0.982
Gene Damage Prediction
All | Recessive | Dominant | |
---|---|---|---|
Mendelian | Medium | Medium | Medium |
Primary Immunodeficiency | Medium | Medium | Medium |
Cancer | Medium | Medium | Medium |
Mouse Genome Informatics
- Gene name
- Lig1
- Phenotype
- immune system phenotype; hematopoietic system phenotype; mortality/aging (the observable characteristics related to the ability of a mammalian organism to live and age that are manifested throughout development and life span); neoplasm; embryo phenotype; liver/biliary system phenotype; homeostasis/metabolism phenotype; cellular phenotype; growth/size/body region phenotype; integument phenotype (the observable morphological and physiological characteristics of the skin and its associated structures, such as the hair, nails, sweat glands, sebaceous glands and other secretory glands that are manifested through development and lifespan); endocrine/exocrine gland phenotype;
Gene ontology
- Biological process
- DNA ligation;lagging strand elongation;DNA repair;transcription-coupled nucleotide-excision repair;base-excision repair;nucleotide-excision repair, DNA gap filling;mismatch repair;anatomical structure morphogenesis;V(D)J recombination;DNA ligation involved in DNA repair;cell division;DNA biosynthetic process;Okazaki fragment processing involved in mitotic DNA replication
- Cellular component
- nucleus;nucleoplasm;cytoplasm;mitochondrion;intracellular membrane-bounded organelle
- Molecular function
- DNA binding;DNA ligase activity;DNA ligase (ATP) activity;ATP binding;metal ion binding